c-Jun NH2 Terminal Kinase Activation and Decreased Expression of Mitogen-Activated Protein Kinase Phosphatase-1 Play Important Roles in Invasion and Angiogenesis of Urothelial Carcinomas
- 1 September 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 171 (3), 1003-1012
- https://doi.org/10.2353/ajpath.2007.070010
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Mitogen-Activated Protein Kinase Phosphatase-1 Is Required for Cisplatin ResistanceCancer Research, 2006
- IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathwayBiochemical and Biophysical Research Communications, 2006
- Phosphorylation status of Fas-associated death domain-containing protein (FADD) is associated with prostate cancer progressionThe Journal of Pathology, 2005
- Inhibition of Tumor Growth, Angiogenesis, and Tumor Cell Proliferation by a Small Molecule Inhibitor of c-Jun N-terminal KinaseJournal of Pharmacology and Experimental Therapeutics, 2004
- Mitogen-Activated Protein Kinase Phosphatase-1 Is Overexpressed in Non-Small Cell Lung Cancer and Is an Independent Predictor of Outcome in PatientsClinical Cancer Research, 2004
- FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassemblyNature Cell Biology, 2004
- Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosisCarcinogenesis: Integrative Cancer Research, 2004
- The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progressionUrologic Oncology: Seminars and Original Investigations, 2004
- JNK phosphorylates paxillin and regulates cell migrationNature, 2003
- The Hallmarks of CancerCell, 2000